Skip to main content
. 2014 Sep 23;136(41):14413–14416. doi: 10.1021/ja508808v

Figure 4.

Figure 4

(A) RNAi signatures derived from the treatment of Eμ-Mycp19arf–/– lymphoma cells with 1, ER stress inducers tunicamycin and thapsigargin, and DNA-cross-linking agents cisplatin, carboplatin, and chlorambucil at the LD80–90 concentration for each compound. (B) Principal components analysis plot of the RNAi signatures.